Sanofi Bangladesh Limited was part of global biopharmaceutical company Sanofi S.A. before the majority stake (54.6%) acquisition by Beximco Pharmaceuticals Limited on October 1, 2021. Sanofi Bangladesh started its operation in Bangladesh as part of the British chemical company May & Baker in 1958. Following a series of mergers and acquisitions (Fisons of United Kingdom, Rhône-Poulenc of France and Hoechst Marion Roussel of Germany) it became known as Sanofi-Aventis in 2004, before being renamed in 2013 as Sanofi Bangladesh Limited.

Synovia Pharma has inherited Sanofi Bangladesh's state-of-the-art manufacturing facilities, including a PIC/s certifiable manufacturing facility for cephalosporin antibiotics, are spread over 25 acres of land, located at Tongi, Gazipur Bangladesh.

Synovia Pharma is continuing to manufacture and market Sanofi products in Bangladesh, just as before, and in addition the new company will provide an expanded portfolio of products to address the unmet medical needs of the patients. Synovia Pharma remains committed to value creation via synergy of strengths of the two ethical entities and will continue to bring hope, health and happiness in the lives of people we touch.